Henrik Sillesen

15.1k total citations · 2 hit papers
207 papers, 7.4k citations indexed

About

Henrik Sillesen is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Henrik Sillesen has authored 207 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 136 papers in Pulmonary and Respiratory Medicine, 103 papers in Cardiology and Cardiovascular Medicine and 89 papers in Surgery. Recurrent topics in Henrik Sillesen's work include Cerebrovascular and Carotid Artery Diseases (94 papers), Cardiovascular Health and Disease Prevention (54 papers) and Peripheral Artery Disease Management (44 papers). Henrik Sillesen is often cited by papers focused on Cerebrovascular and Carotid Artery Diseases (94 papers), Cardiovascular Health and Disease Prevention (54 papers) and Peripheral Artery Disease Management (44 papers). Henrik Sillesen collaborates with scholars based in Denmark, France and United States. Henrik Sillesen's co-authors include Børge G. Nordestgaard, Torben V. Schroeder, Marie-Louise M. Grønholdt, Pierre Amarenco, Michael G. Hennerici, Alfred Callahan, Justin A. Zivin, K.M.A. Welch, Jens E. Wilhjelm and Larry B. Goldstein and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Henrik Sillesen

200 papers receiving 7.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Genetically Elevated C-Reactive Protein and Ischemic Vascular Disease

2008 623 citations Peer Grande, Henrik Sillesen et al. profile →
Prevalence, Impact, and Predictive Value of Detecting Subclinical Coronary and Carotid Atherosclerosis in Asymptomatic Adults

2015 297 citations Usman Baber, Roxana Mehran et al. Journal of the American College of Cardiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Henrik Sillesen Denmark	45	3.6k	3.4k	2.4k	2.0k	1.2k	207	7.4k
Gert J. de Borst Netherlands	45	5.3k 1.5×	4.2k 1.2×	2.4k 1.0×	2.9k 1.4×	660 0.5×	429	9.6k
Hans‐Henning Eckstein Germany	48	6.7k 1.9×	4.1k 1.2×	2.2k 0.9×	2.4k 1.2×	611 0.5×	413	9.2k
Ellisiv B. Mathiesen Norway	48	2.5k 0.7×	4.1k 1.2×	762 0.3×	1.4k 0.7×	720 0.6×	200	7.8k
Glenn M. LaMuraglia United States	51	6.4k 1.8×	3.0k 0.9×	3.5k 1.4×	852 0.4×	1.0k 0.8×	195	8.6k
Martin Schillinger Austria	56	4.9k 1.4×	2.6k 0.8×	5.2k 2.1×	1.5k 0.8×	396 0.3×	247	10.9k
Rishi Puri United States	51	1.9k 0.5×	5.6k 1.7×	4.4k 1.8×	2.8k 1.4×	2.1k 1.7×	363	9.9k
Christian Seiler Switzerland	55	3.4k 0.9×	5.1k 1.5×	5.9k 2.4×	1.2k 0.6×	2.7k 2.2×	293	11.2k
Yehuda Adler Israel	50	1.2k 0.3×	6.3k 1.9×	1.9k 0.8×	2.8k 1.4×	1.0k 0.8×	179	8.4k
Geneviève Dérumeaux France	53	3.0k 0.8×	9.6k 2.8×	2.1k 0.9×	3.3k 1.6×	2.9k 2.4×	219	13.4k
Paul Steendijk Netherlands	53	2.2k 0.6×	9.2k 2.7×	2.5k 1.0×	1.1k 0.5×	1.6k 1.3×	247	11.8k

Countries citing papers authored by Henrik Sillesen

Since Specialization

Citations

This map shows the geographic impact of Henrik Sillesen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henrik Sillesen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henrik Sillesen more than expected).

Fields of papers citing papers by Henrik Sillesen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henrik Sillesen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henrik Sillesen. The network helps show where Henrik Sillesen may publish in the future.

Co-authorship network of co-authors of Henrik Sillesen

This figure shows the co-authorship network connecting the top 25 collaborators of Henrik Sillesen. A scholar is included among the top collaborators of Henrik Sillesen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henrik Sillesen. Henrik Sillesen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Meseguer, Elena, Peter Ganz, Warren Bao, et al.. (2025). Fourteen Biomarkers and Subsequent Disability in Patients with Stroke Recurrence: Results from the SPARCL Trial. European Neurology. 88(3-4). 103–112.

Karin, et al.. (2025). Rivaroxaban Does Not Alter Carotid Plaque Echolucency, Volume, or Neovascularisation. European Journal of Vascular and Endovascular Surgery. 71(3). 354–363.

Pham, Michael Huy Cuong, Jørgen Tobias Kühl, Andreas Fuchs, et al.. (2024). Determinants of thoracic aortic size in normotensive and hypertensive individuals. Journal of Hypertension. 42(10). 1736–1742.

Mazzolai, Lucia, J. J. F. Belch, Maarit Venermo, et al.. (2024). Exercise Therapy for Chronic Symptomatic Peripheral Artery Disease: A Clinical Consensus Document of the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases in Collaboration With the European Society of Vascular Medicine and the European Society for Vascular Surgery. Journal of Vascular Surgery. 79(5). 1262–1262.

Eldrup, Nikolaj, et al.. (2023). Proteomic analysis of extracellular matrix of human atherosclerotic plaques shows marked changes between plaque types. Free Radical Biology and Medicine. 208. S85–S85. 1 indexed citations

Gencer, Bariş, Chris P Gale, Suleman Aktaa, et al.. (2022). European Society of Cardiology quality indicators for the cardiovascular pre-operative assessment and management of patients considered for non-cardiac surgery. Developed in collaboration with the European Society of Anaesthesiology and Intensive Care. European Heart Journal - Quality of Care and Clinical Outcomes. 9(4). 331–341. 7 indexed citations

Landler, Nino Emanuel, Tor Biering‐Sørensen, Klaus F. Kofoed, et al.. (2021). Carotid plaque thickness is increased in chronic kidney disease and associated with carotid and coronary calcification. PLoS ONE. 16(11). e0260417–e0260417. 10 indexed citations

Knudsen, Andreas Dehlbæk, Marco Gelpi, Shoaib Afzal, et al.. (2018). Prevalence of Peripheral Artery Disease is Higher in Persons Living with HIV Compared to Uninfected Controls. UCL Discovery (University College London). 3 indexed citations

Sillesen, Henrik, Nikolaj Eldrup, J. Lindeman, et al.. (2015). Randomized clinical trial of mast cell inhibition in patients with a medium-sized abdominal aortic aneurysm. British journal of surgery. 102(8). 894–901. 64 indexed citations

10.

Baber, Usman, Roxana Mehran, Samantha Sartori, et al.. (2014). DETECTION AND IMPACT OF SUBCLINICAL CORONARY AND CAROTID ATHEROSCLEROSIS ON CARDIOVASCULAR RISK PREDICTION AND RECLASSIFICATION IN ASYMPTOMATIC US ADULTS: INSIGHTS FROM THE HIGH RISK PLAQUE BIOIMAGE STUDY. Journal of the American College of Cardiology. 63(12). A998–A998. 8 indexed citations

11.

Pedersen, Sune, Martin Græbe, Anne Mette Fisker Hag, et al.. (2013). (18)F-FDG imaging of human atherosclerotic carotid plaques reflects gene expression of the key hypoxia marker HIF-1α.. PubMed Central. 21 indexed citations

12.

Sillesen, Henrik, Pieter Muntendam, Aram Adourian, et al.. (2012). Carotid Plaque Burden as a Measure of Subclinical Atherosclerosis. JACC. Cardiovascular imaging. 5(7). 681–689. 209 indexed citations

13.

Tybjærg‐Hansen, Anne, Christiane L. Haase, Børge G. Nordestgaard, et al.. (2011). Heterozygosity for R1141X in ABCC6 and Risk of Ischemic Vascular Disease. Circulation Cardiovascular Genetics. 4(5). 534–541. 23 indexed citations

14.

Sillesen, Henrik & Erling Falk. (2011). Why not screen for subclinical atherosclerosis?. The Lancet. 378(9792). 645–646. 45 indexed citations

15.

Amarenco, Pierre, Larry B. Goldstein, Henrik Sillesen, et al.. (2010). Coronary Heart Disease Risk in Patients With Stroke or Transient Ischemic Attack and No Known Coronary Heart Disease. Stroke. 41(3). 426–430. 36 indexed citations

16.

Amarenco, Pierre, Oscar Benavente, Larry B. Goldstein, et al.. (2009). Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial by Stroke Subtypes. Stroke. 40(4). 1405–1409. 177 indexed citations

17.

Sillesen, Henrik, Pierre Amarenco, Michael G. Hennerici, et al.. (2008). Atorvastatin Reduces the Risk of Cardiovascular Events in Patients With Carotid Atherosclerosis. Stroke. 39(12). 3297–3302. 173 indexed citations

18.

Campese, Vito M., Alfred Callahan, Amy E. Rudolph, et al.. (2007). Abstract 2173: Effect of High-dose Atorvastatin on Changes in Renal Function: A Secondary Analysis of the Stroke Prevention by Aggressive Reduction of Cholesterol Levels (SPARCL) Trial. Circulation. 116. 1 indexed citations

19.

Grønholdt, M.-L.M., Børge G. Nordestgaard, Torben V. Schroeder, S. Vorstrup, & Henrik Sillesen. (2001). Ultrasonic echolucent carotid plaques predict future strokes. Atherosclerosis Supplements. 2(2). 43–43. 2 indexed citations

20.

Sillesen, Henrik, et al.. (1987). The clinical use of objective quantification of flow disturbance in carotid artery disease: Correlation between spectral broadening index and arteriography. Ultrasound in Medicine & Biology. 13(9). 519–525. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact